CyberKnife

CyberKnife: Robotic Radiosurgery for Precise Radiation Treatment

CyberKnife is an advanced robotic radiation delivery system used to treat selected tumours and certain non-cancerous conditions with highly focused radiation. It is designed to deliver radiation accurately from many different angles, helping radiation oncology teams target the treatment area while limiting exposure to nearby healthy tissue.

Despite its name, CyberKnife does not involve a surgical blade. It is a non-invasive form of stereotactic radiation treatment. For many suitable patients, it may provide an alternative to conventional surgery or a shorter-course alternative to some traditional radiation treatment plans.

At Acibadem International, CyberKnife treatment is planned and delivered by experienced radiation oncology professionals working within a multidisciplinary team. Your care may involve radiation oncologists, medical physicists, radiation therapists, diagnostic imaging specialists, surgeons, medical oncologists and other clinicians according to your diagnosis.

For international patients, the treatment journey is coordinated carefully from the first review of medical reports through treatment planning, appointments, travel timing and follow-up recommendations. Suitability always depends on a personal medical assessment.

What Is CyberKnife?

CyberKnife is a robotic radiosurgery system that delivers high-dose, precisely shaped radiation to a defined target. It can be used for stereotactic radiosurgery, often called SRS, and stereotactic body radiation therapy, often called SBRT or SABR.

Stereotactic treatment uses detailed imaging and computer-guided planning to identify the tumour or treatment target in three dimensions. The system then directs multiple small radiation beams toward that target. Each individual beam carries a limited dose as it passes through surrounding tissue, while the combined dose is concentrated at the planned treatment site.

The robotic arm can move around the patient and deliver radiation from a wide range of positions. This flexibility can be valuable for targets that are close to sensitive structures or located in parts of the body that move naturally with breathing, digestion or normal body position changes.

CyberKnife is not appropriate for every diagnosis, tumour type or stage of disease. Your radiation oncology team considers factors such as the location and size of the lesion, previous treatments, overall health, imaging findings and the goals of care before recommending a treatment approach.

How CyberKnife Works

CyberKnife treatment begins with a detailed assessment and treatment-planning process. Specialists review imaging scans and, when needed, pathology reports, operative notes and information about previous radiation, chemotherapy, surgery or other therapies.

High-quality imaging, such as CT, MRI or PET/CT when clinically appropriate, helps the team define the treatment target and identify nearby organs that need protection. The radiation oncologist outlines the area to be treated, while medical physicists and dosimetrists create a personalised radiation plan.

During treatment, the CyberKnife system uses image guidance to verify the position of the target. Depending on the area being treated, it may track bony anatomy, implanted markers or tumour movement patterns. For lesions affected by breathing, the system can be used with motion-management techniques that help account for movement during the treatment session.

The robotic arm delivers radiation from multiple carefully planned angles. This approach allows the treatment team to shape the radiation dose around the target while seeking to reduce radiation exposure to surrounding healthy tissues and critical structures.

Individual Planning Is Essential

CyberKnife is a sophisticated technology, but technology is only one part of care. The quality of treatment also depends on expert diagnosis, accurate imaging, careful planning, safety checks and ongoing clinical oversight.

Your team will discuss whether CyberKnife is intended to treat a tumour definitively, manage a local recurrence, control a limited number of metastatic lesions, relieve symptoms or complement another treatment. The expected outcome and possible alternatives will be explained in relation to your individual situation.

Clinical Applications

CyberKnife may be considered for selected lesions in the brain, spine and body. The final decision is made by a radiation oncology team after reviewing your medical history, imaging and treatment goals.

Clinical applications	Examples of conditions that may be considered	How CyberKnife may be used
Brain and intracranial conditions	Selected brain tumours, brain metastases, acoustic neuroma, meningioma, arteriovenous malformations and trigeminal neuralgia	Highly focused stereotactic radiosurgery may be used to treat a precisely defined target while protecting nearby neurological structures where possible.
Spinal lesions	Selected primary spinal tumours, spinal metastases and recurrent lesions	Stereotactic treatment may be considered when precision is especially important because of the spinal cord and surrounding nerves.
Lung tumours	Selected early-stage lung cancers, limited lung metastases and lesions in patients who may not be suitable for surgery	SBRT may deliver focused radiation over a limited number of sessions, often with motion management for breathing-related movement.
Liver and abdominal lesions	Selected liver tumours, liver metastases, pancreatic lesions and adrenal metastases	Image-guided treatment may help target lesions in areas where nearby organs and natural movement require careful planning.
Prostate cancer	Selected localised prostate cancer and some recurrence situations	CyberKnife may be considered as a stereotactic body radiation option for appropriately selected patients.
Other limited metastatic disease	Selected metastases in the body, depending on their number, location, size and previous treatment	Focused treatment may be used as part of an individual multidisciplinary cancer management plan.

The conditions listed above are examples rather than a guarantee of eligibility. Some tumours are better treated with surgery, systemic therapy, conventional radiation therapy, active surveillance or a combination of treatments. In some cases, CyberKnife may be used after earlier treatment; in others, prior radiation may affect whether further stereotactic radiation can be given safely.

Benefits and Advantages for Patients

CyberKnife can offer important advantages for selected patients because it combines robotic positioning, detailed treatment planning and image-guided radiation delivery. The most meaningful benefit depends on the diagnosis, target location, the need for other therapies and the patient’s overall health.

Unlike open surgery, CyberKnife treatment does not require an incision. Many patients receive treatment as outpatients and can return to their accommodation after each session, provided their medical team agrees that this is appropriate.

For some conditions, CyberKnife can reduce the number of radiation visits compared with longer conventional radiation courses. However, a shorter treatment course is not always the best or safest option. Your radiation oncologist will recommend the approach that best matches your clinical needs.

Patient benefits at a glance	What this may mean for your care
Non-invasive treatment	No surgical incision is required for radiation delivery, which may reduce the need for wound care and surgical recovery.
High treatment precision	Detailed planning and image guidance help focus radiation on the intended target while aiming to limit dose to surrounding healthy tissue.
Robotic flexibility	The robotic arm can deliver radiation from multiple angles, supporting treatment of targets in complex anatomical locations.
Motion-aware technology	For suitable body sites, image guidance and motion-management methods can help account for changes in target position, including movement related to breathing.
Potentially fewer treatment visits	Some patients may complete stereotactic treatment in a limited number of sessions, depending on the clinical plan.
Outpatient-focused experience	Many treatments are performed without hospital admission, which can be helpful when planning travel and accommodation.
Multidisciplinary decision-making	Your case can be reviewed with relevant specialists so the technology is used within a broader, individual treatment strategy.

What to Expect During CyberKnife Treatment

Before You Travel

International patients can begin by sharing recent medical reports, pathology results, imaging studies and treatment summaries for an initial review. The international patient team helps organise communication with the appropriate specialists and supports the coordination of your consultation and potential treatment plan.

Where possible, submitting imaging in its original digital format can help the clinical team assess the case more thoroughly. You may be asked for additional information, updated scans or translated reports before a treatment recommendation can be confirmed.

Your coordinator can help you understand the expected sequence of appointments, how long you may need to remain in Türkiye and what documents may be useful before travel. Treatment timing varies significantly between patients because planning requirements differ according to the diagnosis and treatment site.

Consultation and Assessment

At your consultation, the radiation oncologist reviews your diagnosis, symptoms, previous treatment and current imaging. You will have the opportunity to discuss the proposed treatment, expected goals, alternatives, possible side effects and follow-up plan.

If CyberKnife is suitable, your team will explain the preparation needed for your treatment area. For example, some patients may require a customised immobilisation mask for head and neck treatment or a body support device to help maintain a comfortable, reproducible position.

Simulation and Treatment Planning

Before radiation can be delivered, a planning scan is required. This is often a CT simulation scan, sometimes combined with MRI, PET/CT or other imaging. The scans allow the team to map the target precisely and create a plan tailored to your anatomy.

For certain tumours, small markers may be used to improve target localisation. If this is needed, your physician will explain the procedure, its purpose and any related considerations. Not every patient requires markers.

The treatment plan undergoes detailed review and quality assurance before the first session. This preparation is an essential part of safe stereotactic radiation treatment and may take time. Your team will keep you informed about the schedule.

On the Day of Treatment

CyberKnife treatment is generally painless. You will lie on a treatment couch while the robotic arm moves around you. The machine may change position several times, but it does not touch you during radiation delivery.

You will need to remain still, but the team will help you find a comfortable position. Depending on the treatment site, the session may include imaging checks to confirm the target position. You can communicate with the treatment team throughout the procedure.

Most patients do not need general anaesthesia. The number and duration of sessions vary widely. Some stereotactic treatments are completed in a single session, while others are delivered across several visits. Your radiation oncologist will explain what is planned for you.

After Treatment

Many patients can leave after treatment and continue with light daily activities if they feel well. Your team may advise you to rest, maintain hydration and follow any site-specific instructions. If you have received medication related to swelling, pain, nausea or another symptom, take it exactly as prescribed.

Follow-up imaging is usually arranged after treatment, but the timing depends on the condition being treated. Radiation effects can develop gradually, and scans may show changes that require expert interpretation. Your physicians will explain how your response will be monitored.

Possible Side Effects and Safety Considerations

Every radiation treatment can cause side effects. The type, timing and likelihood of side effects depend on the treatment location, radiation dose, size of the target, nearby organs, previous therapies and individual health factors.

Some patients experience temporary tiredness. Other possible effects are specific to the treated area. For example, treatment near the brain may be associated with headache, swelling or temporary neurological symptoms in some cases. Lung treatment can be associated with cough, shortness of breath or inflammation of lung tissue. Abdominal or pelvic treatment may affect bowel, bladder or digestive function.

Serious complications are uncommon but can occur, particularly when targets are close to important structures or when patients have received radiation previously. Your radiation oncologist will discuss risks that are relevant to your case before treatment begins.

Contact your treating team promptly if you develop new or worsening symptoms after treatment, such as severe pain, significant shortness of breath, persistent vomiting, confusion, seizures, sudden weakness, high fever or any symptom that concerns you.

Safety, Quality Assurance and Accreditation

CyberKnife treatment requires rigorous planning, verification and quality assurance. At Acibadem International, radiation treatment is delivered within JCI-accredited hospital environments, with established clinical processes focused on patient safety, accurate treatment delivery and coordinated care.

Radiation oncologists, medical physicists and radiation therapists work together throughout the treatment pathway. The plan is reviewed before treatment, and technology-based checks are used to support accurate positioning and radiation delivery.

Accreditation reflects an organisational commitment to quality and safety standards, but it does not replace individual clinical judgement. The most appropriate treatment is always determined by the patient’s diagnosis, medical history and multidisciplinary evaluation.

Why CyberKnife Matters for International Patients

Travelling abroad for cancer care or complex radiation treatment can feel overwhelming. International patients often need more than access to advanced technology; they need clear information, coordinated appointments and support in understanding a treatment plan away from home.

Acibadem International provides coordination support for international patients throughout the process. This may include arranging specialist reviews, helping organise consultations, supporting communication in your preferred language and guiding you through the clinical schedule.

If CyberKnife is recommended, the team can help you understand the likely treatment stages and the expected time needed for assessment, planning, treatment and early follow-up. This helps patients and families make informed travel arrangements while recognising that medical timelines may need to change if further tests or consultations are required.

For patients returning home after treatment, the care team can provide medical documentation and follow-up recommendations to share with local doctors. Continued monitoring may involve remote review of reports when clinically appropriate, together with follow-up care in your home country.

Frequently Asked Questions

Is CyberKnife safe?

CyberKnife is an established technology used by trained radiation oncology teams for selected conditions. It includes image guidance and detailed treatment planning, but all radiation treatment carries potential risks. Your team will explain the safety considerations, expected benefits and possible side effects for your individual case.

Is CyberKnife the same as surgery?

No. CyberKnife does not remove a tumour through an incision. It uses focused radiation to damage tumour cells and limit their ability to grow. The biological response to radiation may occur gradually over time, depending on the condition being treated.

Will I need to stay in hospital?

Many CyberKnife treatments are performed on an outpatient basis. However, admission may be recommended in selected circumstances, especially if you need additional procedures, close observation or treatment for another medical condition.

How many sessions will I need?

The number of sessions depends on the diagnosis, tumour location, size, proximity to sensitive organs, previous treatment and clinical objective. Some patients receive one session, while others need several sessions over a planned period.

Will my insurance cover CyberKnife treatment?

Insurance coverage depends on your policy, medical indication and insurer requirements. You can share your insurance details with the international patient team, who can help clarify available options and explain the treatment process before you proceed.

How do I get started?

You can submit your medical reports and imaging for a specialist review through a consultation request. The relevant team will assess whether CyberKnife may be appropriate and explain the recommended next steps for your individual treatment plan.